Large gap with delayed quotes
|
Last quote
07/03/2025
-
20:20:00
|
Bid
07/03/2025 -
18:59:59
|
Bid Volume |
Ask
07/03/2025 -
18:59:59
|
Ask Volume |
|---|---|---|---|---|
|
13.01
0.00
(
0.00% )
|
13.00
|
800 |
13.01
|
1,700 |
Analysis date: 01.07.2025
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 01.07.2025.
Interest
Weak
Weak
Two stars since 24.06.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 24.06.2025 at a price of 10.89.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 30.05.2025.
4wk Rel Perf
23.20%
23.20%
The four-week dividend-adjusted overperformance versus SP500 is 23.20%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 6.15%.
Mkt Cap in $bn
1.45
1.45
With a market capitalization <$2bn, 10X GENOMICS INCO. is considered a small-cap stock.
G/PE Ratio
0.24
0.24
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
-12.82
-12.82
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
3.11%
3.11%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
15
15
Over the last seven weeks, an average of 15 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
145
145
For 1% of index variation, the stock varies on average by 1.45%.
Correlation
0.43
0.43
43.05% of stock movements are explained by index variations.
Value at Risk
8.92
8.92
The value at risk is estimated at USD 8.92. The risk is therefore 73.97%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
04.09.2020
04.09.2020